Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 258

1.

Evaluation of 4-methylcyclohexanemethanol (MCHM) in a combined irritancy and Local Lymph Node Assay (LLNA) in mice.

Johnson VJ, Auerbach SS, Luster MI, Waidyanatha S, Masten SA, Wolfe MS, Burleson FG, Burleson GR, Germolec DR.

Food Chem Toxicol. 2017 Jul;105:99-105. doi: 10.1016/j.fct.2017.03.034. Epub 2017 Mar 22.

2.

Association of MHC region SNPs with irritant susceptibility in healthcare workers.

Yucesoy B, Talzhanov Y, Michael Barmada M, Johnson VJ, Kashon ML, Baron E, Wilson NW, Frye B, Wang W, Fluharty K, Gharib R, Meade J, Germolec D, Luster MI, Nedorost S.

J Immunotoxicol. 2016 Sep;13(5):738-44. doi: 10.3109/1547691X.2016.1173135. Epub 2016 Jun 3.

3.

Genetic Basis of Irritant Susceptibility in Health Care Workers.

Yucesoy B, Talzhanov Y, Barmada MM, Johnson VJ, Kashon ML, Baron E, Wilson NW, Frye B, Wang W, Fluharty K, Gharib R, Meade J, Germolec D, Luster MI, Nedorost S.

J Occup Environ Med. 2016 Aug;58(8):753-9. doi: 10.1097/JOM.0000000000000784.

4.

N-Acetyltransferase 2 Genotypes Are Associated With Diisocyanate-Induced Asthma.

Yucesoy B, Kissling GE, Johnson VJ, Lummus ZL, Gautrin D, Cartier A, Boulet LP, Sastre J, Quirce S, Tarlo SM, Cruz MJ, Munoz X, Luster MI, Bernstein DI.

J Occup Environ Med. 2015 Dec;57(12):1331-6. doi: 10.1097/JOM.0000000000000561.

5.

Genetic variants in TNFα, TGFB1, PTGS1 and PTGS2 genes are associated with diisocyanate-induced asthma.

Yucesoy B, Kashon ML, Johnson VJ, Lummus ZL, Fluharty K, Gautrin D, Cartier A, Boulet LP, Sastre J, Quirce S, Tarlo SM, Cruz MJ, Munoz X, Luster MI, Bernstein DI.

J Immunotoxicol. 2016;13(1):119-26. doi: 10.3109/1547691X.2015.1017061. Epub 2015 Sep 4.

6.

A critical examination of the mode of action of quinacrine in the reproductive tract in a 2-year rat cancer bioassay and its implications for human clinical use.

Haseman JK, Growe RG, Zeiger E, McConnell EE, Luster MI, Lippes J.

Regul Toxicol Pharmacol. 2015 Apr;71(3):371-8. doi: 10.1016/j.yrtph.2015.02.006. Epub 2015 Feb 10.

7.

Genetic variants in the major histocompatibility complex class I and class II genes are associated with diisocyanate-induced Asthma.

Yucesoy B, Johnson VJ, Lummus ZL, Kashon ML, Rao M, Bannerman-Thompson H, Frye B, Wang W, Gautrin D, Cartier A, Boulet LP, Sastre J, Quirce S, Tarlo SM, Germolec DR, Luster MI, Bernstein DI.

J Occup Environ Med. 2014 Apr;56(4):382-7. doi: 10.1097/JOM.0000000000000138.

8.

Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate.

Looker C, Luster MI, Calafat AM, Johnson VJ, Burleson GR, Burleson FG, Fletcher T.

Toxicol Sci. 2014 Mar;138(1):76-88. doi: 10.1093/toxsci/kft269. Epub 2013 Nov 27.

9.

A historical perspective of immunotoxicology.

Luster MI.

J Immunotoxicol. 2014 Jul-Sep;11(3):197-202. doi: 10.3109/1547691X.2013.837121. Epub 2013 Oct 1. Review.

PMID:
24083808
10.

Genetic variants within the MHC region are associated with immune responsiveness to childhood vaccinations.

Yucesoy B, Talzhanov Y, Johnson VJ, Wilson NW, Biagini RE, Wang W, Frye B, Weissman DN, Germolec DR, Luster MI, Barmada MM.

Vaccine. 2013 Nov 4;31(46):5381-91. doi: 10.1016/j.vaccine.2013.09.026. Epub 2013 Sep 26.

11.

Winter season, frequent hand washing, and irritant patch test reactions to detergents are associated with hand dermatitis in health care workers.

Callahan A, Baron E, Fekedulegn D, Kashon M, Yucesoy B, Johnson VJ, Domingo DS, Kirkland B, Luster MI, Nedorost S.

Dermatitis. 2013 Jul-Aug;24(4):170-5. doi: 10.1097/DER.0b013e318290c57f.

12.

Reductions in serum lipids with a 4-year decline in serum perfluorooctanoic acid and perfluorooctanesulfonic acid.

Fitz-Simon N, Fletcher T, Luster MI, Steenland K, Calafat AM, Kato K, Armstrong B.

Epidemiology. 2013 Jul;24(4):569-76. doi: 10.1097/EDE.0b013e31829443ee. Erratum in: Epidemiology. 2013 Nov;24(6):941.

13.

Quinacrine-induced occlusive fibrosis in the human fallopian tube is due to a unique inflammatory response and modification of repair mechanisms.

Growe RG, Luster MI, Fail PA, Lippes J.

J Reprod Immunol. 2013 Apr;97(2):159-66. doi: 10.1016/j.jri.2012.12.003. Epub 2013 Feb 28. Review.

PMID:
23453701
14.

Immunotoxicology: fifty years of global scientific progress.

McKarns SC, Kerkvliet NI, Dean JH, Bonn MB, Cohen MD, Franko J, Laiosa MD, Lawrence BP, Luebke RW, Luster MI, Miller PG, Palmer RK, Pfau JC, Raman P, Regal JF, Rodgers KE, Schondelmeyer RS, Zhang X, Burns-Naas LA.

J Immunotoxicol. 2012 Oct-Dec;9(4):339-40. doi: 10.3109/1547691X.2012.658530. Epub 2012 Oct 19.

PMID:
23078377
15.

CTNNA3 (α-catenin) gene variants are associated with diisocyanate asthma: a replication study in a Caucasian worker population.

Bernstein DI, Kashon M, Lummus ZL, Johnson VJ, Fluharty K, Gautrin D, Malo JL, Cartier A, Boulet LP, Sastre J, Quirce S, Germolec D, Tarlo SM, Cruz MJ, Munoz X, Luster MI, Yucesoy B.

Toxicol Sci. 2013 Jan;131(1):242-6. doi: 10.1093/toxsci/kfs272. Epub 2012 Sep 13.

16.

Genetic variants in antioxidant genes are associated with diisocyanate-induced asthma.

Yucesoy B, Johnson VJ, Lummus ZL, Kissling GE, Fluharty K, Gautrin D, Malo JL, Cartier A, Boulet LP, Sastre J, Quirce S, Germolec DR, Tarlo SM, Cruz MJ, Munoz X, Luster MI, Bernstein DI.

Toxicol Sci. 2012 Sep;129(1):166-73. doi: 10.1093/toxsci/kfs183. Epub 2012 May 17.

17.

Association of osteoarthritis with serum levels of the environmental contaminants perfluorooctanoate and perfluorooctane sulfonate in a large Appalachian population.

Innes KE, Ducatman AM, Luster MI, Shankar A.

Am J Epidemiol. 2011 Aug 15;174(4):440-50. doi: 10.1093/aje/kwr107. Epub 2011 Jun 27.

18.

Hexamethylene diisocyanate asthma is associated with genetic polymorphisms of CD14, IL-13, and IL-4 receptor α.

Bernstein DI, Kissling GE, Khurana Hershey G, Yucesoy B, Johnson VJ, Cartier A, Gautrin D, Sastre J, Boulet LP, Malo JL, Quirce S, Tarlo SM, Langmeyer S, Luster MI, Lummus ZL.

J Allergy Clin Immunol. 2011 Aug;128(2):418-20. doi: 10.1016/j.jaci.2011.03.007. Epub 2011 Apr 13. No abstract available.

19.

An alternative interpretation of, "A lifetime cancer bioassay of quinacrine administered into the uterine horns of female rats".

McConnell EE, Lippes J, Growe RG, Fail P, Luster MI, Zeiger E.

Regul Toxicol Pharmacol. 2010 Mar;56(2):166-73. doi: 10.1016/j.yrtph.2009.12.007. Epub 2010 Jan 4.

PMID:
20043971
20.

Immunotoxicology testing: past and future.

Luster MI, Gerberick GF.

Methods Mol Biol. 2010;598:3-13. doi: 10.1007/978-1-60761-401-2_1. Review.

PMID:
19967502
21.

Influence of cytokine gene variations on immunization to childhood vaccines.

Yucesoy B, Johnson VJ, Fluharty K, Kashon ML, Slaven JE, Wilson NW, Weissman DN, Biagini RE, Germolec DR, Luster MI.

Vaccine. 2009 Nov 23;27(50):6991-7. doi: 10.1016/j.vaccine.2009.09.076. Epub 2009 Oct 9.

PMID:
19819209
22.

Meeting report: moving upstream-evaluating adverse upstream end points for improved risk assessment and decision-making.

Woodruff TJ, Zeise L, Axelrad DA, Guyton KZ, Janssen S, Miller M, Miller GG, Schwartz JM, Alexeeff G, Anderson H, Birnbaum L, Bois F, Cogliano VJ, Crofton K, Euling SY, Foster PM, Germolec DR, Gray E, Hattis DB, Kyle AD, Luebke RW, Luster MI, Portier C, Rice DC, Solomon G, Vandenberg J, Zoeller RT.

Environ Health Perspect. 2008 Nov;116(11):1568-75. doi: 10.1289/ehp.11516. Epub 2008 Jul 10. Review.

23.

Suppression of immune function and susceptibility to infections in humans: association of immune function with clinical disease.

Luebke RW, Parks C, Luster MI.

J Immunotoxicol. 2004 Jan;1(1):15-24. doi: 10.1080/15476910490438342.

PMID:
18958637
24.

Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha.

DeWitt JC, Shnyra A, Badr MZ, Loveless SE, Hoban D, Frame SR, Cunard R, Anderson SE, Meade BJ, Peden-Adams MM, Luebke RW, Luster MI.

Crit Rev Toxicol. 2009;39(1):76-94. doi: 10.1080/10408440802209804 . Review.

PMID:
18802816
25.

Association of cytokine gene polymorphisms with rate of decline in lung function.

Yucesoy B, Kurzius-Spencer M, Johnson VJ, Fluharty K, Kashon ML, Guerra S, Luster MI, Burgess JL.

J Occup Environ Med. 2008 Jun;50(6):642-8. doi: 10.1097/JOM.0b013e31816515e1.

PMID:
18545091
26.

Genetic susceptibility to progressive massive fibrosis in coal miners.

Yucesoy B, Johnson VJ, Kissling GE, Fluharty K, Kashon ML, Slaven J, Germolec D, Vallyathan V, Luster MI.

Eur Respir J. 2008 Jun;31(6):1177-82. doi: 10.1183/09031936.00075107. Epub 2008 Feb 6.

27.

Variation in the WBC differential count and other factors associated with reporting of herpes labialis: a population-based study of adults.

Parks CG, Andrew ME, Blanciforti LA, Luster MI.

FEMS Immunol Med Microbiol. 2007 Nov;51(2):336-43. Epub 2007 Aug 29.

28.

Inhalation of toluene diisocyanate vapor induces allergic rhinitis in mice.

Johnson VJ, Yucesoy B, Reynolds JS, Fluharty K, Wang W, Richardson D, Luster MI.

J Immunol. 2007 Aug 1;179(3):1864-71.

29.

Cardiovascular effects of pulmonary exposure to single-wall carbon nanotubes.

Li Z, Hulderman T, Salmen R, Chapman R, Leonard SS, Young SH, Shvedova A, Luster MI, Simeonova PP.

Environ Health Perspect. 2007 Mar;115(3):377-82. Epub 2006 Dec 4.

30.

A statistical model for assessing genetic susceptibility as a risk factor in multifactorial diseases: lessons from occupational asthma.

Demchuk E, Yucesoy B, Johnson VJ, Andrew M, Weston A, Germolec DR, De Rosa CT, Luster MI.

Environ Health Perspect. 2007 Feb;115(2):231-4. Epub 2006 Nov 13. Erratum in: Environ Health Perspect. 2007 May;115(5):A241.

31.

Genetic susceptibility in pneumoconiosis.

Yucesoy B, Luster MI.

Toxicol Lett. 2007 Feb 5;168(3):249-54. Epub 2006 Nov 16. Review.

PMID:
17161563
32.

Immunotoxicogenomics: the potential of genomics technology in the immunotoxicity risk assessment process.

Luebke RW, Holsapple MP, Ladics GS, Luster MI, Selgrade M, Smialowicz RJ, Woolhiser MR, Germolec DR.

Toxicol Sci. 2006 Nov;94(1):22-7. Epub 2006 Aug 1.

33.

Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-alpha.

Sriram K, Matheson JM, Benkovic SA, Miller DB, Luster MI, O'Callaghan JP.

FASEB J. 2006 Apr;20(6):670-82.

PMID:
16581975
34.

The comparative immunotoxicity of five selected compounds following developmental or adult exposure.

Luebke RW, Chen DH, Dietert R, Yang Y, King M, Luster MI; Immunotoxicology Workgroup.

J Toxicol Environ Health B Crit Rev. 2006 Jan-Feb;9(1):1-26. Review.

PMID:
16393867
35.

Association of interleukin-1 gene polymorphisms with dementia in a community-based sample: the Honolulu-Asia Aging Study.

Yucesoy B, Peila R, White LR, Wu KM, Johnson VJ, Kashon ML, Luster MI, Launer LJ.

Neurobiol Aging. 2006 Feb;27(2):211-7. Epub 2005 Apr 7.

PMID:
16226351
36.
37.

Maternal treatment with a high dose of CpG ODN during gestation alters fetal craniofacial and distal limb development in C57BL/6 mice.

Prater MR, Johnson VJ, Germolec DR, Luster MI, Holladay SD.

Vaccine. 2006 Jan 16;24(3):263-71. Epub 2005 Aug 22.

PMID:
16143434
38.

Biomarkers to assess potential developmental immunotoxicity in children.

Luster MI, Johnson VJ, Yucesoy B, Simeonova PP.

Toxicol Appl Pharmacol. 2005 Aug 7;206(2):229-36. Review.

PMID:
15967213
39.

Lack of association between antioxidant gene polymorphisms and progressive massive fibrosis in coal miners.

Yucesoy B, Johnson VJ, Kashon ML, Fluharty K, Vallyathan V, Luster MI.

Thorax. 2005 Jun;60(6):492-5.

40.

Exposure and immunological determinants in a murine model for toluene diisocyanate (TDI) asthma.

Matheson JM, Johnson VJ, Vallyathan V, Luster MI.

Toxicol Sci. 2005 Mar;84(1):88-98. Epub 2004 Dec 8.

PMID:
15590891
41.

Immune mediators in a murine model for occupational asthma: studies with toluene diisocyanate.

Matheson JM, Johnson VJ, Luster MI.

Toxicol Sci. 2005 Mar;84(1):99-109. Epub 2004 Dec 8.

PMID:
15590890
42.

A proposed testing framework for developmental immunotoxicology (DIT).

Holsapple MP, Burns-Naas LA, Hastings KL, Ladics GS, Lavin AL, Makris SL, Yang Y, Luster MI.

Toxicol Sci. 2005 Jan;83(1):18-24. Epub 2004 Sep 29.

PMID:
15456913
43.

The accuracy of extended histopathology to detect immunotoxic chemicals.

Germolec DR, Kashon M, Nyska A, Kuper CF, Portier C, Kommineni C, Johnson KA, Luster MI.

Toxicol Sci. 2004 Dec;82(2):504-14. Epub 2004 Sep 1.

PMID:
15342959
44.
45.

Symposium summary: children's health risk--what's so special about the developing immune system?

Holsapple MP, Paustenbach DJ, Charnley G, West LJ, Luster MI, Dietert RR, Burns-Naas LA.

Toxicol Appl Pharmacol. 2004 Aug 15;199(1):61-70. Review.

PMID:
15289091
46.

Arsenic and atherosclerosis.

Simeonova PP, Luster MI.

Toxicol Appl Pharmacol. 2004 Aug 1;198(3):444-9. Review.

PMID:
15276425
47.

Arsenic and urinary bladder cell proliferation.

Luster MI, Simeonova PP.

Toxicol Appl Pharmacol. 2004 Aug 1;198(3):419-23. Review.

PMID:
15276422
48.

Associating changes in the immune system with clinical diseases for interpretation in risk assessment.

Luster MI, Germolec DR, Parks CG, Blaciforti L, Kashon M, Luebke R.

Curr Protoc Toxicol. 2004;Chapter 18:Unit18.1. doi: 10.1002/0471140856.tx1801s20.

PMID:
23045101
49.

Role of CC chemokines in skeletal muscle functional restoration after injury.

Warren GL, O'Farrell L, Summan M, Hulderman T, Mishra D, Luster MI, Kuziel WA, Simeonova PP.

Am J Physiol Cell Physiol. 2004 May;286(5):C1031-6. Epub 2004 Jan 14.

50.

Animal models for diisocyanate asthma: answers for lingering questions.

Johnson VJ, Matheson JM, Luster MI.

Curr Opin Allergy Clin Immunol. 2004 Apr;4(2):105-10. Review.

PMID:
15021062

Supplemental Content

Loading ...
Support Center